153 related articles for article (PubMed ID: 31509457)
1. Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best Disease.
Subbiah D; Hashim H; Chew FLM
Ocul Immunol Inflamm; 2020 Oct; 28(7):1149-1151. PubMed ID: 31509457
[TBL] [Abstract][Full Text] [Related]
2. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of ranibizumab for pregnant women in idiopathic choroidal neovascularization.
Jouve L; Akesbi J; Nordmann JP
Acta Ophthalmol; 2015 Nov; 93(7):e597-8. PubMed ID: 25483229
[No Abstract] [Full Text] [Related]
4. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
Sudhalkar A; Yogi R; Chhablani J
Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
[TBL] [Abstract][Full Text] [Related]
5. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
6. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
7. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].
Prieto-Calvo E; Torrón-Fernández Blanco C; Egea-Estopiñán C; Güerri-Monclús N; Ferrer-Novella E; Ruiz-Moreno O; Pablo-Julvez LE
Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.
Ruiz-Moreno O; Calvo P; Ferrández B; Torrón C
Acta Ophthalmol; 2012 Nov; 90(7):e574-5. PubMed ID: 22339886
[No Abstract] [Full Text] [Related]
9. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
[TBL] [Abstract][Full Text] [Related]
11. Structural and optical coherence tomography angiography in myopic choroidal neovascularization: Agreement with conventional fluorescein angiography.
Iacono P; Giorno P; Varano M; Parravano M
Eur J Ophthalmol; 2021 Jan; 31(1):149-157. PubMed ID: 31619075
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ranibizumab for choroidal neovascularization secondary to gyrate atrophy in a young patient: a multimodal imaging analysis.
Chatziralli I; Theodossiadis G; Emfietzoglou I; Theodossiadis P
Eur J Ophthalmol; 2015 Oct; 25(6):e119-22. PubMed ID: 26419008
[TBL] [Abstract][Full Text] [Related]
13. Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study.
Furino C; Di Antonio L; Grassi MO; Rispoli M; Reibaldi M; Niro A; Alessio G
Eur J Ophthalmol; 2019 May; 29(3):323-329. PubMed ID: 30101614
[TBL] [Abstract][Full Text] [Related]
14. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.
Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D
Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.
Chhablani J; Jalali S
Eur J Ophthalmol; 2012; 22(4):677-9. PubMed ID: 22139615
[TBL] [Abstract][Full Text] [Related]
16. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
Cheng Y; Li Y; Huang X; Qu Y
Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
[TBL] [Abstract][Full Text] [Related]
17. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
19. Long term follow-up after a single intravitreal ranibizumab injection for choroidal neovascularisation secondary to optic nerve head drusen in a 5-year-old child.
Baillif S; Nguyen E; Colleville-El Hayek A; Bétis F
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1657-9. PubMed ID: 23093047
[No Abstract] [Full Text] [Related]
20. Ranibizumab in the treatment of choroidal neovascularization associated with morning glory syndrome.
Cennamo G; Rossi C; Velotti N; de Crecchio G
Acta Ophthalmol; 2015 Sep; 93(6):e516-7. PubMed ID: 25726749
[No Abstract] [Full Text] [Related]
[Next] [New Search]